Integra LifeSciences Holdings Management
Management criteria checks 3/4
Integra LifeSciences Holdings' CEO is Jan De Witte, appointed in Dec 2021, has a tenure of 2.58 years. total yearly compensation is $6.39M, comprised of 13.7% salary and 86.3% bonuses, including company stock and options. directly owns 0.023% of the company’s shares, worth €486.40K. The average tenure of the management team and the board of directors is 3.3 years and 11.2 years respectively.
Key information
Jan De Witte
Chief executive officer
US$6.4m
Total compensation
| CEO salary percentage | 13.7% |
| CEO tenure | 2.6yrs |
| CEO ownership | 0.02% |
| Management average tenure | 3.3yrs |
| Board average tenure | 11.2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$40m |
| Dec 31 2023 | US$6m | US$875k | US$68m |
| Sep 30 2023 | n/a | n/a | US$101m |
| Jun 30 2023 | n/a | n/a | US$131m |
| Mar 31 2023 | n/a | n/a | US$172m |
| Dec 31 2022 | US$9m | US$850k | US$181m |
| Sep 30 2022 | n/a | n/a | US$173m |
| Jun 30 2022 | n/a | n/a | US$166m |
| Mar 31 2022 | n/a | n/a | US$157m |
| Dec 31 2021 | US$899k | US$59k | US$169m |
Compensation vs Market: Jan's total compensation ($USD6.39M) is above average for companies of similar size in the German market ($USD1.54M).
Compensation vs Earnings: Jan's compensation has been consistent with company performance over the past year.
CEO
Jan De Witte (60 yo)
2.6yrs
Tenure
US$6,388,756
Compensation
Mr. Jan De Witte has been President, Chief Executive Officer & Director of Integra LifeSciences Holdings Corporation since December 1, 2021. He had been the Chief Executive Officer at Barco NV since Septem...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 26.6yrs | US$422.52k | 2.23% $ 46.5m | |
| President | 2.6yrs | US$6.39m | 0.023% $ 486.4k | |
| Executive VP & CFO | 1.1yrs | US$1.67m | 0.056% $ 1.2m | |
| Senior VP of Finance & Principal Accounting Officer | 6.8yrs | US$1.25m | 0.047% $ 988.1k | |
| Executive VP | 5.7yrs | US$1.62m | 0.081% $ 1.7m | |
| Executive VP & President of Tissue Technologies | 11.6yrs | US$1.42m | 0.083% $ 1.7m | |
| Executive VP & President of Codman Specialty Surgical | 4.2yrs | US$2.83m | 0.073% $ 1.5m | |
| Corporate VP of Global Operations & Supply Chain | 3.9yrs | no data | no data | |
| Vice President of Global Corporate Communications & Public Relations | no data | no data | no data | |
| Vice President of Global Marketing | no data | no data | no data | |
| Executive VP & Chief Human Resources Officer | 1.5yrs | no data | 0.033% $ 683.6k | |
| Corporate VP & Chief Digital Officer | 2.5yrs | no data | no data |
3.3yrs
Average Tenure
57yo
Average Age
Experienced Management: IL3's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 26.6yrs | US$422.52k | 2.23% $ 46.5m | |
| President | 2.6yrs | US$6.39m | 0.023% $ 486.4k | |
| Independent Director | 15.3yrs | US$297.54k | 0.11% $ 2.2m | |
| Independent Director | 18.5yrs | US$293.28k | 0.081% $ 1.7m | |
| Independent Presiding Director | 11.2yrs | US$342.54k | 0.17% $ 3.6m | |
| Independent Director | 32.5yrs | US$306.31k | 0.089% $ 1.9m | |
| Independent Director | less than a year | US$90.68k | 0.016% $ 331.2k | |
| Independent Director | 3.3yrs | US$260.04k | 0.028% $ 581.0k | |
| Independent Director | 2yrs | US$297.54k | 0.021% $ 428.1k |
11.2yrs
Average Tenure
63yo
Average Age
Experienced Board: IL3's board of directors are seasoned and experienced ( 11.2 years average tenure).